Evofem Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Evofem Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Evofem Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 96.5M shares, a 2177% increase year-over-year.
  • Evofem Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 4.83M shares, a 936% increase from 2022.
  • Evofem Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 466K shares, a 94.7% decline from 2021.
  • Evofem Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 8.73M shares, a 87% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 96.5M +92.2M +2177% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 66.8M +65.2M +4136% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 31.2M +29.9M +2353% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 4.83M +4.36M +936% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 4.24M +3.58M +542% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 1.58M +1.36M +626% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 1.27M +1.18M +1333% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 466K -8.26M -94.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 659K -9.62M -93.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 217K -8.13M -97.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 88.7K -5.37M -98.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-06-16
Q4 2021 8.73M Oct 1, 2021 Dec 31, 2021 10-K 2023-04-27
Q3 2021 10.3M -70.9M -87.3% Jul 1, 2021 Sep 30, 2021 10-Q 2023-01-06
Q2 2021 8.34M -49.4M -85.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 5.46M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 81.2M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 57.7M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.